[Use of glatiramer acetate (Copaxone) in the treatment of patients with multiple sclerosis. Experience of the Moscow multiple sclerosis center]

Autor:	T L, Demina, M V, Davydovskaia, N Iu, Lashch, N F, Popova, N V, Khachanova, T D, Zhuchenko
Rok vydání:	2003
Předmět:	Adult Male Adolescent T-Lymphocytes Brain Glatiramer Acetate HLA-DR Antigens Middle Aged Multiple Sclerosis Chronic Progressive Magnetic Resonance Imaging Axons Drug Administration Schedule Multiple Sclerosis Relapsing-Remitting Adjuvants Immunologic Humans Female Peptides
Zdroj:	Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. (Spec No 2)
ISSN:	1997-7298
Popis:	146 patients with multiple sclerosis are treated by copaxone in the Moscow MS Centre. The relaps exacerbation rate decreased by 72%, the relapse rate reduced by 25.6% during the copaxone treatment. EDSS score did not increase both in group with and without relapses. The condition of 2/3 patients was stable. To achieve the best effect of treatment the program of patient support was successfully used in the Moscow MS Centre.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::994fbe4c7ff85fd69bb43801484e49ef https://pubmed.ncbi.nlm.nih.gov/12938642 Zobrazit plný text záznamu